Evidence map›Paper›PMID 39584582›Full record

ReviewJournal of cellular physiology2025

Signaling Regulation of FAM134-Dependent ER-Phagy in Cells.

Alessandro Palma, Alessio Reggio

Abstract readReview
In one paragraph

Review in Journal of cellular physiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Alessandro PalmaDepartment of Biology and Biotechnologies "Charles Darwin", Sapienza University of Rome, Rome, Italy.ORCID 0000-0003-1300-5479
Alessio ReggioSaint Camillus International University of Health Sciences, Rome, Italy.ORCID 0000-0001-5333-7502

Funding

This study was supported by European Union - NextGenerationEU: National Center for Gene Therapy and Drug based on RNA Technology, CN3 - Spoke 3 (code: CN00000041; PNRR MUR - M4C2 - Action 1.4-Call "Potenziamento Strutture di ricerca e di Campioni Nazionali di R&S", CUP: B83C22002870006) and AFM-Téléthon grant number 23551.
6 · The paper itself

Abstract

The endoplasmic reticulum (ER) is a pivotal organelle responsible for protein and lipid synthesis, calcium homeostasis, and protein quality control within eukaryotic cells. To maintain cellular health, damaged or excess portions of the ER must be selectively degraded via a process known as selective autophagy, or ER-phagy. This specificity is driven by a network of protein receptors and regulatory mechanisms. In this review, we explore the molecular mechanisms governing ER-phagy, with a focus on the FAM134 family of ER-resident ER-phagy receptors. We discuss the molecular pathways and Posttranslational modifications that regulate receptor activation and clustering, and how these modifications fine-tune ER-phagy in response to stress. This review provides a concise understanding of how ER-phagy contributes to cellular homeostasis and highlights the need for further studies in models where ER stress and autophagy are dysregulated.

Indexed as

AutophagyEndoplasmic ReticulumEndoplasmic Reticulum StressIntracellular Signaling Peptides and ProteinsMembrane ProteinsSignal TransductionAnimalsHumansProtein Processing, Post-TranslationalIntracellular Signaling Peptides and ProteinsMembrane ProteinsRETREG1 protein, humanautophagyendoplasmic reticulumER‐phagyFAM134Bubiquitination

Identifiers

PMID39584582
PMCPMC11747952

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.